Pharma giant Lilly acquires Insilico's end-to-end AI drug discovery platform for $115M+. See how AI identifies targets, generates molecules, and fast-tracks drugs into clinical trials. 🎧 Watch the full episode of What the AI?! YouTube, Spotify, Apple Podcasts → https://www.whattheai.fm #AIDrugDiscovery #PharmaTech #Insilico #Eli Lilly #ClinicalTrials